Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 12
Submit an article Journal homepage
250
Views
10
CrossRef citations to date
0
Altmetric
Original Article: Clinical

The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma

Naoto TomitaDepartment of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan; Correspondence[email protected]
,
Taisei SuzukiDepartment of Hematology, Yokosuka City Hospital, Yokosuka, Japan;
,
Kazuho MiyashitaDepartment of Hematology/Immunology, Fujisawa City Hospital, Fujisawa, Japan;
,
Wataru YamamotoDepartment of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan;
,
Kenji MotohashiDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan;
,
Takayoshi TachibanaDepartment of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan;
,
Hirotaka TakasakiDepartment of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan;
,
Rika KawasakiDepartment of Hematology/Immunology, Fujisawa City Hospital, Fujisawa, Japan;
,
Maki HagiharaDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan;
,
Chizuko HashimotoDepartment of Hematology/Oncology, Yamato Municipal Hospital, Yamato, Japan;
,
Sachiya TakemuraDepartment of Internal Medicine, Yokohama Ekisaikai Hospital, Yokohama, Japan;
,
Hideyuki KoharazawaDepartment of Hematology, Shizuoka Red Cross Hospital, Shizuoka, Japan;
,
Etsuko YamazakiDepartment of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan;
,
Jun TaguchiDepartment of Hematology, Shizuoka Red Cross Hospital, Shizuoka, Japan;
,
Katsumichi FujimakiDepartment of Hematology/Immunology, Fujisawa City Hospital, Fujisawa, Japan;
,
Hiroyuki FujitaDepartment of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan;
,
Rika SakaiDepartment of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan;
,
Shin FujisawaDepartment of Hematology, Yokohama City University Medical Center, Yokohama, Japan;
,
Shigeki MotomuraDepartment of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan;
,
Keisuke KawamotoDepartment of Hematology, Endocrinology, and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan
,
Hirohito SoneDepartment of Hematology, Endocrinology, and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan
&
Jun TakizawaDepartment of Hematology, Endocrinology, and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan
 show all
Pages 2763-2770 | Received 10 Feb 2016, Accepted 24 May 2016, Published online: 20 Jun 2016

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Shin-Ichi Ochi, Takashi Nagayama, Kiyomi Mashima, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Kaoru Morita, Yasufumi Kawasaki, Chihiro Yamamoto, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi & Yoshinobu Kanda. (2019) Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 60:8, pages 1926-1933.
Read now
Adam J. Olszewski. (2016) Formulating a novel prognostic index for diffuse large B-cell lymphoma: T cells break the SILence. Leukemia & Lymphoma 57:12, pages 2733-2735.
Read now

Articles from other publishers (8)

Thomas Wimmer, Raphael Mattes, Hans-Joachim Stemmler, Fabian Hauck, Hendrik Schulze-Koops, Stephanie-Susanne Stecher, Michael Starck, Clemens-Martin Wendtner, Peter Bojko, Marcus Hentrich, Katharina E. Nickel, Katharina S. Götze, Florian Bassermann, Michael von Bergwelt-Baildon & Karsten Spiekermann. (2023) sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study. Blood Advances 7:5, pages 832-844.
Crossref
Hussein M Khaled, Thoraya M Abdelhamid, Fouad M Abu-Taleb, Niveen M El-Hifnawi & Ahmad B Waley. (2019) Impact of serum levels of IL-18 and soluble IL-2 receptor on the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP regimen. Future Science OA 5:9.
Crossref
Kento Umino, Shin-ichiro Fujiwara, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Shin-ichi Ochi, Takashi Nagayama, Kiyomi Mashima, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Kaoru Morita, Yasufumi Kawasaki, Chihiro Yamamoto, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi & Yoshinobu Kanda. (2019) Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapy. Annals of Hematology 98:9, pages 2121-2129.
Crossref
Jelena Jelicic, Thomas Stauffer Larsen, Milos Maksimovic & Goran Trajkovic. (2019) Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic review. Critical Reviews in Oncology/Hematology 133, pages 1-16.
Crossref
Joel C. Wight, Geoffrey Chong, Andrew P. Grigg & Eliza A. Hawkes. (2018) Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. Blood Reviews 32:5, pages 400-415.
Crossref
Yian Zhang, Zheng Wei, Jing Li, Rupan Gao & Peng Liu. (2018) Monoclonal gammopathies regardless of subtypes are associated with poor prognosis of diffuse large B-cell lymphoma. Medicine 97:30, pages e11719.
Crossref
Zhongqi Li, Qi Guo, Juying Wei, Jie Jin & Jinghan Wang. (2018) Geriatric nutritional risk index is not an independent predictor in patients with diffuse large B-cell lymphoma. Cancer Biomarkers 21:4, pages 813-820.
Crossref
Molly Lin, Sujin Park, Anna Hayden, Dean Giustini, Martina Trinkaus, Morris Pudek, Andre Mattman, Marion Schneider & Luke Y.C. Chen. (2017) Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review. Annals of Hematology 96:8, pages 1241-1251.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.